
- Low testosterone diagnosis
- Symptoms plus two early-morning total testosterone results below about 300 ng/dL (AUA)
- TRT monitoring
- Hematocrit, PSA for men over 40, blood pressure
- Fertility
- Testosterone therapy suppresses sperm production
- Peptides with strong evidence
- GLP-1 medicines for weight management
It often starts with testosterone
Testosterone tends to decline gradually with age, and lower levels can contribute to fatigue, reduced sex drive, erectile changes and loss of muscle. But a lower number isn't automatically a diagnosis. The American Urological Association recommends confirming low testosterone with two early-morning tests on separate days, with under 300 ng/dL as a reasonable cutoff, and only when symptoms are present.
Weight, sleep apnea, alcohol, opioids and some other medicines can all lower testosterone. Sometimes addressing them raises levels without hormone treatment.
What testosterone therapy involves
When low testosterone is confirmed, testosterone therapy is an established treatment. The FDA updated testosterone labels in 2025 to add results of the TRAVERSE trial, which found no increase in major cardiovascular events in men with hypogonadism, while adding class-wide warnings about blood pressure increases.
Monitoring matters. The AUA recommends checking hemoglobin and hematocrit before treatment because testosterone can raise red blood cell counts, and measuring PSA in men over 40. Testosterone also suppresses sperm production, so it shouldn't be prescribed to men trying to conceive. For those men, options such as enclomiphene, which encourages the body to make more of its own testosterone, are sometimes considered; enclomiphene is not FDA-approved.
Where peptides come in
- GLP-1 medicines: strong evidence for weight loss in men with obesity or overweight and a related health condition. Branded versions are FDA-approved; compounded versions are not.
- Sermorelin: prompts the pituitary to release growth hormone. It's discussed for recovery, sleep and body composition, with limited evidence in healthy midlife men.
- BPC-157 and TB-500: popular for injuries and recovery, with mostly animal data. Not FDA-approved, and their compounding status was still under FDA review in October 2026.
- PT-141: acts on desire pathways in the brain; use in men is off-label.
- Tadalafil: not a peptide, but a well-studied, FDA-approved option for erectile dysfunction and urinary symptoms of an enlarged prostate.
A sequence that makes sense
- Measure: morning testosterone (twice if low), hematocrit, PSA where appropriate, A1c, lipids, thyroid and iron.
- Screen for sleep apnea if you snore, gasp at night or are sleepy during the day.
- Treat the foundation: confirmed low testosterone, sleep problems, weight and blood pressure.
- Train for strength at least 2 days a week and eat enough protein.
- Then consider a peptide for a specific remaining goal, with a clear way to measure progress.
The honest take on men's peptide marketing
Many products promise muscle, fat loss and youthful energy without the side effects of hormones. For most of these peptides, the claims run well ahead of the evidence, which is largely from animals or small, short human studies. The FDA has also flagged several growth hormone-releasing peptides, including ipamorelin and CJC-1295, for safety concerns.
If you compete in tested sport, many peptides are prohibited, including BPC-157 under the WADA list.
Don't normalize a treatable problem
It's common to put midlife fatigue down to age or work. Sometimes that's right. But untreated sleep apnea raises the risk of stroke and heart attack, low testosterone affects bone and muscle, and prediabetes is reversible when caught early. A proper evaluation is more useful than any supplement or peptide while those questions are open.
Body composition and the muscle priority
For most men in midlife, the single most useful physical goal is keeping and building muscle. Muscle supports blood sugar control, joint health, balance and the ability to stay active into later decades.
That means progressive strength training, enough protein and adequate sleep, whether or not you use testosterone or a peptide. If you're losing weight with a GLP-1 medicine, those habits matter even more, because rapid weight loss can include lean tissue. Tracking a few lifts and your waist size tells you more than the scale about whether a plan is working.
How HealifyMD approaches men's care
A licensed clinician reviews your symptoms, history and labs, then builds a plan. Listed prices include testosterone therapy at $249 for the first month (including the lab panel), then $149/month; enclomiphene/DHEA/boron/pregnenolone ODT from $129/month; tadalafil daily from $99/month; and sermorelin ODT from $199/month. Compounded products are not FDA-approved. Prices are confirmed at your eligibility review, and other labs are priced separately.
Common questions
Should I try peptides or testosterone therapy?
If testing confirms low testosterone with symptoms, treating that is usually the first step. Peptides are best considered afterward for specific goals.
Can peptides help me lose my midsection?
GLP-1 medicines have strong evidence for fat loss. Most other peptides don't, and strength training and diet remain central.
Are men's performance peptides proven?
Mostly not. Many have only animal or small human studies, and some have been flagged by the FDA for safety concerns.
Is peptide therapy safe with testosterone therapy?
It can be under supervision, but combinations are rarely studied. Your clinician will add one change at a time and monitor labs.
Will testosterone therapy affect my fertility?
Yes. It suppresses sperm production, so men who want children should discuss alternatives before starting.
Do I need a PSA test?
The AUA recommends measuring PSA in men over 40 before starting testosterone therapy.
Where should I start?
With an assessment and morning labs, plus a sleep screen if you snore or feel sleepy during the day.
Sources
We cite government agencies, professional societies and peer-reviewed research. See our editorial policy.
- Testosterone Deficiency GuidelineAmerican Urological Association
- FDA Issues Class-Wide Labeling Changes for Testosterone ProductsU.S. Food and Drug Administration
- Testosterone Levels TestMedlinePlus (U.S. National Library of Medicine)
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety RisksU.S. Food and Drug Administration
- Sleep ApneaNational Heart, Lung, and Blood Institute
- BPC-157: What Athletes Should KnowU.S. Anti-Doping Agency